Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease is a clinical trial[1].
Key Facts
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease is in the country of United States[2].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's instance of is recorded as clinical trial[3].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's start time is recorded as +2012-02-29T00:00:00Z[4].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's end time is recorded as +2017-07-31T00:00:00Z[5].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's sponsor is recorded as Eunice Kennedy Shriver National Institute of Child Health and Human Development[6].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's main subject is recorded as colitis[7].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's number of participants is recorded as {'unit': '1', 'amount': '+140'}[8].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's title is recorded as Telehealth Enhancement of Adherence to Medication in Pediatric Inflammatory Bowel Disease[9].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's short name is recorded as TEAM[10].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+11'}[11].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's ClinicalTrials.gov ID is recorded as NCT01536509[12].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[13].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's clinical trial phase is recorded as phase III clinical trial[14].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's research site is recorded as University of Cincinnati[15].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's research site is recorded as Cincinnati Children's Hospital Medical Center[16].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's research site is recorded as Children's Hospital of Philadelphia[17].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's research site is recorded as Connecticut Children's Medical Center[18].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's research site is recorded as Oklahoma State University[19].
- Improving Medication Adherence in Pediatric Inflammatory Bowel Disease's study type is recorded as interventional study[20].